+++ US-Zollpolitik +++: Lula und Trump wollen Zoll-Verhandlungen fortsetzen

The United States and Canada have agreed to postpone the implementation of new U.S. tariffs on Canadian imports, granting both nations time for further negotiations. In a statement on Tuesday evening, U.S. President Donald Trump announced the temporary suspension of the planned 50 percent tariffs on Canadian goods, citing the successful resolution of agreements between the two countries. The targeted products, valued at approximately $20 billion annually, include hockey sticks and medical wood augers.

Earlier in the week, Canadian Prime Minister Mark Carney attempted to prevent further retaliatory tariffs through a phone call with Trump. The tariffs, set to take effect at midnight, would target around five percent of Canada's annual exports to the U.S. The Canadian government's primary contention centers on the calculation basis for future tariff reductions, with the U.S. demanding that only domestically produced content be considered, while Canada insists on including all North American components, including those from Canada and Mexico.

The tariffs, based on a 1962 U.S. law, were initially announced to protect domestic industry from Chinese competition. President Trump also imposed minimum prices and tariffs on polysilicon products and set minimum import prices starting December 4th for polysilicon, blocks and wafers, solar cells, and solar modules. Each stage of the supply chain for chips and solar panels relies on polysilicon, which is processed into wafers and eventually into modules.

Before the first vehicles were expected to cross the Gordie Howe International Bridge on Monday, Canada organized a billion-dollar inauguration ceremony without U.S. officials. Trump had previously extended the bridge's inauguration with additional tariff threats on various Canadian goods, including hockey sticks, wine, and cement.

The tariffs, scheduled to take effect 30 days after signing on August 19th, are the subject of a congressional investigation into the practice of "siphoning" American companies and the U.S. taxpayer. American pharmaceutical manufacturer Sartorius compensated customers for unlawfully paid U.S. tariffs, dampening the company's first-half revenue growth.

The conglomerate reported a nominal revenue increase of 2.5 percent in the first six months, reaching 1.81 billion euros, after excluding compensation payments and currency effects.